Stay updated on Pembrolizumab After Chemotherapy/Proton Reirradiation Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab After Chemotherapy/Proton Reirradiation Clinical Trial page.

Latest updates to the Pembrolizumab After Chemotherapy/Proton Reirradiation Clinical Trial page
- Check2 days agoNo Change Detected
- Check10 days agoChange DetectedThe page now includes new user-guidance sections (How to Read a Study Record, Common Questions, How to Join a Study) and shows the study status as completed with No longer looking for participants. A formatting tweak standardizes the Intervention/Treatment label and the revision note updates to Revision: v3.6.0.SummaryDifference0.5%

- Check17 days agoChange DetectedRevision: v3.5.5 replaces the prior v3.5.4 in the page metadata, indicating a small update to the page without altering study information.SummaryDifference0.1%

- Check38 days agoChange DetectedThe study's revision label updated to v3.5.4 in the documents section, replacing the previous v3.5.3, signaling a minor update to the protocol materials.SummaryDifference0.1%

- Check53 days agoChange DetectedThe page's revision tag was updated from v3.5.2 to v3.5.3, indicating a new version of the page. This update seems administrative and does not affect the study details shown.SummaryDifference0.1%

- Check67 days agoChange DetectedAdded Revision: v3.5.2; removed Revision: v3.5.0.SummaryDifference0.1%

- Check95 days agoChange DetectedRevision tag updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab After Chemotherapy/Proton Reirradiation Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab After Chemotherapy/Proton Reirradiation Clinical Trial page.